
    
      The study will be organized as follows:

        -  Screening Phase

        -  Single-blind Prospective Treatment Phase

        -  Single-blind Continuation Phase (Responder)or Double-blind Randomization Phase
           (non-Responder)

        -  30 day Post Treatment Follow-up

      Assigned Interventions:

        -  Escitalopram monotherapy

        -  Aripiprazole/Escitalopram combination therapy

        -  Aripiprazole monotherapy
    
  